bpc-157 dosing frequency (Common Protocols), πΉ Oral / Subcutaneous, β’ 500 mcg daily, β’ Duration: 6 weeks, πΉ Intramuscular / Peritendinous, β’ 1 mg daily, β’ Duration: 6 weeks, β οΈ Note:, Not approved by FDA or BPC-157 Dosage Calculator: Units, mL
Description
Because the mechanisms don't overlap, some patients use them together as parts of one supervised plan
Negative results A negative result indicates that the drugs tested for are not present or are not present in a high enough quantity to detect
To reduce the oxidative degradation, the authors proposed the use of methionine (10 mM) as an antioxidant (Doshi et al., 2020b)
Products sold by online peptide stores are concerning because they are unregulated for the safety of these substances
Switch to a 0.3ml (30-unit) insulin syringe, which has finer graduation marks for small volumes
Methyl Depletion: The body loses valuable methyl groups needed for other processes
